UK markets open in 4 hours 25 minutes
NIKKEI 225
38,893.96 +276.86 (+0.72%) HANG SENG
18,790.00 -405.60 (-2.11%) CRUDE OIL
76.94 -0.63 (-0.81%) GOLD FUTURES
2,373.20 -19.70 (-0.82%) DOW
39,671.04 -201.95 (-0.51%) Bitcoin GBP
54,566.04 -616.18 (-1.12%)
QIAGEN N.V. (QIA.F)
Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
At close: 08:14PM CEST
| Previous close | 41.55 |
| Open | 41.28 |
| Bid | 40.09 x 110000 |
| Ask | 40.44 x 110000 |
| Day's range | 39.83 - 41.58 |
| 52-week range | 34.00 - 44.69 |
| Volume | |
| Avg. volume | 1,498 |
| Market cap | 8.954B |
| Beta (5Y monthly) | 0.42 |
| PE ratio (TTM) | 28.83 |
| EPS (TTM) | 1.40 |
| Earnings date | 06 Aug 2024 - 12 Aug 2024 |
| Forward dividend & yield | 1.18 (2.91%) |
| Ex-dividend date | 30 Jan 2024 |
| 1y target est | 47.60 |
Simply Wall St.Estimating The Fair Value Of Qiagen N.V. (NYSE:QGEN)
Key Insights Qiagen's estimated fair value is US$43.31 based on 2 Stage Free Cash Flow to Equity Qiagen's US$45.02...
ZacksHere's Why Investors Should Retain QIAGEN (QGEN) Stock Now
QIAGEN's (QGEN) solid potential in the NGS platform buoys optimism for investors.
ZacksQIAGEN's (QGEN) QCI Interpret Gets European IVDR Certification
QIAGEN's (QGEN) Clinical Insight Interpret is the first NGS interpretation platform approved by IVDR for use in cancer and hereditary applications.
© 2024 Yahoo. All rights reserved.